The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy

Phase 3 Not yet recruiting 244 enrolled Oxagon

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Phase three randomized, double-blinded, study to asses the efficacy and safety of oxytocin gel in postmenopausal women with vaginal atrophy due to Genitourinary Syndrome of Menopause GSM.

Timeline

Start: 2024-09
Primary completion: 2025-06
Completion: 2025-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Oxytocin	Peptide	600 iu	Topical

The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy

Summary

Timeline

Drugs

Indications